Thomas P. Mathers
Bioinformatics and system biology
Declion Pharmaceuticals, Inc
France
Biography
Tom co-founded Déclion in 2011. He has more than twenty five years of executive management experience in the life sciences and medical device industry. Prior to Déclion, Tom served as president and CEO of CoLucid Pharmaceuticals (NASDAQ: CLCD) until its acquisition by Eli LIlly and Company in 2017, president and CEO of Peptimmune, Inc.; president and CEO of Cell Based Delivery; vice president and general manager of Cardion AG; vice president of Strategic Development at Genzyme; and management positions at Snowden-Pencer and Pfizer, Inc. Tom holds several patents and patents pending and earned his BS in Engineering from the United States Military Academy at West Point. From 1988 to 1991 he served as captain in the United States Army and was awarded several medals for his services as an AH-64 Apache helicopter pilot in the Gulf War while serving in the XVIII Airborne Corps.
Research Interest
Bioinformatics and system biology
